Literature DB >> 1513113

Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus.

K Dahl-Jørgensen1, T Bjøro, P Kierulf, L Sandvik, H J Bangstad, K F Hanssen.   

Abstract

In this paper we examined the relationship between blood glucose control and initiation and progression of increased urinary albumin excretion. In this seven year Oslo study 45 insulin-dependent diabetes mellitus patients were initially randomized into three different modes of treatment: continuous subcutaneous insulin infusion (CSII), multiple injections, or two injections a day. After four years, the patients were free to choose their treatment, and therefore the data were analyzed according to mean HbA1 during seven years. The mean HbA1 was 11.2% (2.2) (SD) at start, and 9.5% (1.5) at seven years, which was a significant long-term improvement (P less than 0.001). Eight out of 10 patients with mean seven year HbA1 less than 8.5% improved their albumin excretion rate, and patients with mean HbA1 greater than 10% had an increased albumin excretion rate (from 26 mg/24 hr to 91 mg/24 hr, P less than 0.02). The glomerular filtration rate decreased slightly regardless of mean HbA1 level. Systolic blood pressure increased significantly regardless of mean HbA1. Diastolic blood pressure was unchanged in the patients with mean HbA1 less than 10%, but increased slightly (NS) in patients with HbA1 greater than 10%. We conclude that mean blood glucose as measured by glycosylated hemoglobin is a main determinant in the progression of urinary albumin excretion in insulin dependent diabetics, and near normoglycemia improves urinary albumin excretion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1513113     DOI: 10.1038/ki.1992.140

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study.

Authors:  K F Amthor; K Dahl-Jørgensen; T J Berg; M S Heier; L Sandvik; O Aagenaes; K F Hanssen
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

Review 2.  Blood glucose control and microvascular complications--what do we do now?

Authors:  K Dahl-Jørgensen; O Brinchmann-Hansen; H J Bangstad; K F Hanssen
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

3.  High prevalence and diversity of kidney dysfunction in patients with type 2 diabetes mellitus and coronary artery disease: the BARI 2D baseline data.

Authors:  Barry M Wall; Regina M Hardison; Mark E Molitch; Oscar C Marroquin; Janet B McGill; Phyllis A August
Journal:  Am J Med Sci       Date:  2010-05       Impact factor: 2.378

4.  Effect of protein intake on glycaemic control and renal function in type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  J Pomerleau; M Verdy; D R Garrel; M H Nadeau
Journal:  Diabetologia       Date:  1993-09       Impact factor: 10.122

5.  Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy?

Authors:  E Jungmann; A Felber; S Graeber; U Hillmann; T Haak; K D Palitzsch; K H Usadel
Journal:  Clin Investig       Date:  1993-08

6.  Reduced sensitivity to beta-adrenoceptor stimulation and blockade in insulin dependent diabetic patients with hypoglycaemia unawareness.

Authors:  T S Trovik; R Jaeger; R Jorde; G Sager
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

7.  Improvement of blood glucose control in IDDM patients retards the progression of morphological changes in early diabetic nephropathy.

Authors:  H J Bangstad; R Osterby; K Dahl-Jørgensen; K J Berg; A Hartmann; K F Hanssen
Journal:  Diabetologia       Date:  1994-05       Impact factor: 10.122

Review 8.  A risk-benefit assessment of conventional versus intensive insulin therapy.

Authors:  P Reichard
Journal:  Drug Saf       Date:  1994-03       Impact factor: 5.606

Review 9.  Current therapeutic management of diabetic nephropathy.

Authors:  S M Kohler; B K Krämer
Journal:  Acta Diabetol       Date:  1994-09       Impact factor: 4.280

10.  Intensive therapy and progression to clinical albuminuria in patients with insulin dependent diabetes mellitus and microalbuminuria. Microalbuminuria Collaborative Study Group, United Kingdom.

Authors: 
Journal:  BMJ       Date:  1995-10-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.